Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2011 / 02
PHARMAC documents that matched your search:
Changes to the access and funding of special foods; Contact: Stephen Woodruffe
(29 pages, 347 KB)
2011/02/28
February 2011 Special Foods - Notification of Funding and Access Changes from 1 April Changes to the Access and Funding of Special Foods from 1 April 2011 The PHARMAC Board has made a number of decisions regarding the access and…
February Tender Notification; Contact: Kyle Reid
(5 pages, 117 KB)
2011/02/28
28 February 2011 TENDER RESULTS The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2010/11 Invitation to Tender, dated 2…
Section H - effective 1 March 2011
(78 pages, 550 KB)
2011/02/28
Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 March 2011 New Zealand Pharmaceutical Schedule Hospital Pharmaceuticals March 2011 Editors Kaye Wilson & Rebecca Bloor email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9,…
Clarification of Emergency Supply and Co-Payment Temporary Changes
(1 page, 14 KB)
2011/02/25
Clarification of Emergency Supply and Co-Payment Temporary Changes 1. The emergency supply extension to 7 days supply and being able to claim subsidy for people affected or displaced by the Christchurch earthquake applies to all pharmacies throughout the country. 2.…
Proposal to list a new brand of ornidazole; Closing Date: Closed; Contact: Greg Williams
(2 pages, 120 KB)
2011/02/25
25 February 2011 Proposal to list a new brand of ornidazole PHARMAC is seeking feedback on a provisional agreement it has reached with Arrow Pharmaceuticals (NZ) Limited. In summary, the proposal is to fund Arrow-Ornidazole tablets from 1 May 2011.…
Medsafe: Emergency Supply; Contact: Notifications
(2 pages, 59 KB)
2011/02/24
FA C S I M I L E To All New Zealand Pharmacies, IPA Pharmacy Facilitators and Wholesalers Fax Autodial From Medsafe Subject : Emergency Supply of medicines Date Wednesday 23 February 2011 No of pages 2 In the wake…
Medsafe fax re Emergency supply
(2 pages, 53 KB)
2011/02/24
FA C S I M I L E To All New Zealand Pharmacies, IPA Pharmacy Facilitators and Wholesalers Fax Autodial From Medsafe Subject : Emergency Supply of medicines Date Wednesday 23 February 2011 No of pages 2 In the wake…
Pharmacies (Opening hours, Contact details, Comments)
(2 pages, 63 KB)
2011/02/24
Last updated: 23/02/2011 8:41 p.m. Require Urgent pharm open tomorrow? Organisation Airport Pharmacy Christchurch Ltd Akaroa Pharmacy Alabasters Merivale Pharmacy Amberley Pharmacy Ltd Avonhead Pharmacy ltd Barrington Health Centre Pharmacy Wilsons Barrington Pharmacy Ltd Barrington Unichem Pharmacy Bastins Pharmacy Ltd…
Proposal for nilotinib and imatinib; Closing Date: Closed; Contact: Jackie Evans
(6 pages, 153 KB)
2011/02/24
24 February 2011 Proposal to widen funded access to imatinib and to fund nilotinib for patients with CML PHARMAC is seeking feedback on a proposal to: fund nilotinib (Tasigna) for patients with chronic myeloid leukaemia (CML); and widen…
